Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Diabetes & Clinical Diagnosis Volume 1 (2014), Article ID 1:IJDCD-105, 3 pages
http://dx.doi.org/10.15344/2394-1499/2014/105
Commentary
Vitamin D, Type 2 Diabetic and Cardiovascular Disease: Myth or Reality?

Ana Paula Silva*, Andre Fragoso and Pedro Leao Neves

Servico de Nefrologia Do hospital de Faro, Centro Hospitalar do Algarve, Portugal
Dr. Ana Paula Silva, Servico de Nefrologia Do hospital de Faro, Centro Hospitalar do Algarve, Portugal; Tel: 289-891220; Fax: 289-891221; E-mail: anapassionara@gmail.com
06 June 2014; 06 September 2014; 08 September 2014
Silva AP, Fragoso A, Neves PL (2014) Vitamin D, Type 2 Diabetic and Cardiovascular Disease: Myth or Reality? Int J Diabetes Clin Diagn 1: 105. doi: http://dx.doi.org/10.15344/2394-1499/2014/105
© 2014 Silva et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Harinarayan CV (2014) Vitamin D and diabetes mellitus. Hormones 13: 163-181. View
  2. Schneider LE, Schedl HP, McCain T, Haussler MR (2005) Experimental diabetes reduces circulating 1, 25-dihydroxyvitamin D in the rat. Science 196: 1452-1454. View
  3. The NS, Crandell JL, Lawrence JM, King IB, Dabelea D, et al. (2013) Vitamin D in youth with type 1 diabetes: prevalence of insufficiency and association with insulin resistance in the SEARCH Nutrition Ancillary Study. Diabetic Med 30: 1324-1332. View
  4. Speer G, Cseh K, Winkler G, Vargha P, Braun E, et al. (2001) Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 144: 385-389. View
  5. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, et al. ( 2002) Vitamin D Receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51: 2294-2300. View
  6. Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79: 820-825. View
  7. Guo SW, Magnuson VL, Schiller JJ, Wang X, Wu Y, et al. (2006) Metaanalysis of vitamin D receptor polymorphism and Type 1 diabetes: A HUGE review of genetic association studies. Am J Epidemiol 164: 711-724. View
  8. Mattila C, Knekt P, Rissanen H, Laaksone AM, Montonen J, et al. (2007) Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30: 2569-¬2570. View
  9. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, et al. (2013) Blood 25-hydroxyvitamin D levels and incidente type 2 diabetes. Diabetes Care 36: 1422-1428. View
  10. Hochberg Z, Borochowitz Z, Benderli A, Vardi P, Oren S, et al. (1985) Does 1, 25-dhydroxyvitamin D participate in the regulation of hormone release from endocrine glands? J Clin Endocrinol Metab 60: 57-¬61. View
  11. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, et al. (2004) Expression of 25-hydroxyvitamin D3-1 alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90: 121-12¬5. View
  12. Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, et al. (2012) Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol 11: 1475-¬2840. View
  13. Davidson MB, Duran P, Lee ML, Friedman TC (2013) High-dose vitamin D supplmentation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013; 36: 260-266. View
  14. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-¬2029. View
  15. Mitri J, Dawson-Hughes B, FB, and Pittas AG (2011) Effects of vitamin D and calcium supplementation on pancreatic b cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94: 486-494. View
  16. Bourlon PM, Billaudel B, Faure-Dussert A (1999) Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 160: 87-¬95. View
  17. The EURODIAB substudy 2 Study group (1999) Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia 42: 51-¬54. View
  18. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, et al. (2004) A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type I diabetes developement. J Immunol 173: 2280-¬2287. Artaza JN, Mehrotra R, Norris KC (2009) Vitamin D and the Cardiovascular System. Clin J Am Soc Nephrol 4: 1515– 1522. View
  19. Artaza JN, Mehrotra R, Norris KC (2009) Vitamin D and the Cardiovascular System. Clin J Am Soc Nephrol 4: 1515– 1522. View
  20. Cigolini M, Lagulli MP, Miconi V (2006) Serum 25-hydroxyvitamin D3 concentrations and a prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 29: 722-724. View
  21. Al IMheid I, Patel RS, Tangpricha V, Quyyumi AA (2003) Vitamin D and cardiovascular disease: is the evidence solid? Eur Heart J 34: 3691-3698. View
  22. Harris SS (2011) Does vitamin D deficiency contribute to increased rates of cardiovascular disease and type 2 diabetes in African Americans? Am J Clin Nutr 93: 1175S-1178S. View
  23. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511. View
  24. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, et al. (2007) Prevalence of cardiovascular risk factors and the serum levels of 25- Hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167: 1159-1165. View
  25. Choncholi M, Cigolini M and Targher G (2008) Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol Dial Transplant 23: 269–274. View
  26. Silva AP, Pinho A, Cabrita A (2011) Mineral Metabolism Disturbances and Atherosclerosis in Type 2 Diabetic CKD Patients. J Am Soc Nephrol 22: 225A.
  27. Silva AP, Cabrita A, Pinho A (2011) The Good and the Bad: The Relationships between 25 (OH) D and FGF-23 Levels with Cardiovascular Disease in Type 2 Diabetic CKD Patients. J Am Soc Nephrol 22: 228A.
  28. Wallis DE, Penckofer S, Sizemore GW (2008) The ''Sunshine Deficit'' and cardiovascular Disease. Circulation 118: 1476-1485. View
  29. Garcia VC, Martini LA (2010) Vitamin D and Cardiovascular Disease. Nutrients 2: 426-437. View
  30. Artaza JN, Contreras S, Garcia LA, Mehrotra R, Gibbons G, et al. (2011) Vitamin D and Cardiovascular Disease: Potential Role in Health Disparities. J Health Care Poor Underserved 22: 23-38. View
  31. Manson JE (2010) Vitamin D and the heart: why we need large-scale clinical trials. Cleve Clin J Med 77: 903-910. View
  32. Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, et al. (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease. The PRIMO randomized controlled trial. JAMA 307: 674-684. View
  33. Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, et al. (2001) Vitamin D, cardiovascular disease and mortality. Clin Endocrinol 75: 575–584. View
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.